Learn more about SMA® Xpert ProCol
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
| View in browser
SMA Professional
Shaping the future health of babies
Dear [* data('firstname') || 'Healthcare Professional' *],
Supporting parents of crying infants is part of the care approach to managing feeding issues. In >90% of cases, treatment consists of helping the parents get through this challenging period in the babies development1.

In this months’ webinar, an expert healthcare professional will discuss the evidence on the role of probiotics in the management of feeding issues in infants and young children. We also bring you New SMA® Xpert ProCol, a food supplement containing L.reuteriΔ cultures. L.reuteriΔ is clinically proven to manage symptoms of infantile colic 1-4*
Kind regards,

The SMA® Professional Team
[* IF data('95.pref_website_newsletter') == '0' *] [* ELSE *]
The role of probiotics in the management of Functional Gastrointestinal Disorders in infants & young children. What is the evidence?
In this live webinar a Consultant Paediatrician discusses the supporting evidence behind probiotics and provides an opportunity for questions and answers.

Thursday 14th July, 1-2pm
Functional Gastrointestinal Disorders
[* END *]
New SMA® Xpert ProCol
SMA® Xpert ProCol
New SMA® Xpert ProCol is a food supplement containing L.reuteriΔ cultures. L.reuteriΔ is clinically proven to manage symptoms of infantile colic 1-4*
  1. Szajewska H, et.al. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 2013; 162:257‒262.
  2. Savino F et.al. Lactobacillus reuteri DSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial. Pediatrics 2010;126:e526‒e533.
  3. Chau K, et.al. Probiotics for Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating Lactobacillus reuteri DSM 17938. J Pediatr 2015; 166:74‒8.
  4. Sung V, et.al. Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20171811